Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 447

1.

Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.

Garber AJ, Larsen J, Schneider SH, Piper BA, Henry D; Glyburide/Metformin Initial Therapy Study Group.

Diabetes Obes Metab. 2002 May;4(3):201-8. Erratum in: Diabetes Obes Metab. 2002 Jul;4(4):286..

PMID:
12047399
4.

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy.

Pratley RE, Kipnes MS, Fleck PR, Wilson C, Mekki Q; Alogliptin Study 007 Group.

Diabetes Obes Metab. 2009 Feb;11(2):167-76. doi: 10.1111/j.1463-1326.2008.01016.x.

PMID:
19125778
6.

Effect of glyburide-metformin combination tablet in patients with type 2 diabetes.

Chien HH, Chang CT, Chu NF, Hsieh SH, Huang YY, Lee IT, Lee WJ, Tang YJ, Sheu WH.

J Chin Med Assoc. 2007 Nov;70(11):473-80.

8.
9.

Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy.

Blonde L, Rosenstock J, Mooradian AD, Piper BA, Henry D.

Diabetes Obes Metab. 2002 Nov;4(6):368-75.

PMID:
12406033
10.

Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy.

Garber A, Klein E, Bruce S, Sankoh S, Mohideen P.

Diabetes Obes Metab. 2006 Mar;8(2):156-63.

PMID:
16448519
11.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
13.

Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.

Wang JS, Lin SD, Lee WJ, Su SL, Lee IT, Tu ST, Tseng YH, Lin SY, Sheu WH.

Clin Ther. 2011 Dec;33(12):1932-42. doi: 10.1016/j.clinthera.2011.10.014. Epub 2011 Nov 10.

PMID:
22078152
14.

A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients.

Erle G, Lovise S, Stocchiero C, Lora L, Coppini A, Marchetti P, Merante D.

Acta Diabetol. 1999 Jun;36(1-2):61-5.

PMID:
10436254
18.
19.

The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes.

Chiasson JL, Naditch L; Miglitol Canadian University Investigator Group.

Diabetes Care. 2001 Jun;24(6):989-94.

PMID:
11375358
20.

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial.

Jadzinsky M, Pfützner A, Paz-Pacheco E, Xu Z, Allen E, Chen R; CV181-039 Investigators.

Diabetes Obes Metab. 2009 Jun;11(6):611-22. doi: 10.1111/j.1463-1326.2009.01056.x.

PMID:
19515181

Supplemental Content

Support Center